Overview This page contains the latest trade data of Antisera and other blood fractions. In 2020, Antisera and other blood fractions were the world's 78th most traded product, with a total trade of $29.2B. Between 2019 and 2020 the exports of Antisera and other blood fractions decreased by -0.52%, from $29.3B to $29.2B. Trade in Antisera and other blood fractions represent 0.17% of total world trade.
Antisera and other blood fractions are a part of Vaccines, blood, antisera, toxins and cultures.
Exports In 2020 the top exporters of Antisera and other blood fractions were United States ($7.65B), Germany ($6.69B), Switzerland ($3.15B), Austria ($2.38B), and Australia ($1.53B).
Imports In 2020 the top importers of Antisera and other blood fractions were Germany ($5.24B), United States ($4.99B), Austria ($1.85B), China ($1.65B), and Switzerland ($1.3B).
Tariffs In 2018 the average tariff for Antisera and other blood fractions was 1.72%, making it the 6323rd lowest tariff using the HS6 product classification.
Ranking Antisera and other blood fractions ranks 1232nd in the Product Complexity Index (PCI).